VA-REGULA
Access to international festivals like Sziget and Untold, which draw up to 100,000 visitors daily, has been significantly enhanced. Regula, a global developer of forensic devices and identity verification solutions, and Netpositive, a Hungarian IT service provider specializing in large-scale event management, joined forces to switch to mobile ID verification (IDV) via a special app empowered by IDV software. As a result, Netpositive’s state-of-the-art Backstage Ticketing ecosystem has become an even more valuable asset for event organizers across the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604833546/en/
Netpositive’s new Backstage Ticketing solution for large events’ visitor ID verification based on Regula Document Reader SDK (Graphic: Business Wire)
The backbone of access services to large-scale events is the so-called “redemption” process, during which visitor tickets are checked and exchanged for wristbands with designated access rights. For this process to function properly, it is necessary to identify event visitors by their identity documents.
Netpositive used to handle document verification with the help of designated ID scanners provided by a third-party vendor. Apart from that, the company also employed a range of other devices, such as barcode readers, NFC readers, and laptops. The complexity of managing these devices often led to inefficiencies at event redemption points.
To make the process more productive and streamlined, Netpositive decided to switch to mobile ID verification (IDV) via a special app empowered by IDV software. After performing extensive research and following a partner’s recommendation, Netpositive opted for Regula Document Reader SDK, a comprehensive identity document verification software solution. Within one month, Regula’s solution was seamlessly built into Netpositive’s Backstage Ticketing Access Management App and integrated into their larger ecosystem, where they manage everything from ticket sales to redemption checks to event dashboards.
Regula Document Reader SDK allows Netpositive’s Backstage Ticketing ecosystem to read and verify passports, ID cards, and driver’s licenses with a single mobile device. Not only does Regula’s solution speed up the document check process, but it also enhances security by performing cross-checks to identify any data discrepancies that could indicate fraud. Apart from that, Regula Document Reader SDK re-verifies biometric documents on the server side in the customer’s secure perimeter in order to ensure that the chip is genuine and its data has not been cloned or manipulated, and thus prevent sophisticated fraud. The solution's extensive document template database includes over 13,900 templates from 249 countries and territories, ensuring comprehensive coverage and seamless processing for international event attendees.
Implementing Regula’s technology has already shown remarkable success at recent events, such as Untold Dubai, visited by over 185,000 people, and Massif in Romania, with a capacity of 12,000 people per day. The streamlined mobile solution has reduced queues, cut down manual labor, and received overwhelmingly positive feedback from staff and attendees alike.
In the long run, Netpositive expects to cut expenses on device procurement, and expects to significantly reduce the number of technical problems involved with the redemption process, which were relatively frequent with the previous solution.
“We are still at an early stage of the access admission process transformation, and we assume we will get more tangible results during the coming season of summer festivals. But we are very sure of one thing: with this new solution with the Regula Document Reader SDK at the core, we made a real innovation. The reinvention of the redemption process helped us become more competitive, promoting our position in the market,” says Mátyás Török, Netpositive’s founder and CEO.
"Our collaboration with Netpositive not only showcases the importance of robust and efficient identity verification, but also sets a new standard for access management in large-scale events. We are proud to contribute to creating safer and more efficient event experiences around the globe," says Ihar Kliashchou, Chief Technology Officer at Regula.
For more information on how Netpositive is transforming event access management with Regula’s IDV solutions, read the success story.
About Netpositive
Netpositive creates large-scale, unique, load-proof digital solutions. With more than 50 partners, 500 international events, and 36 million unique users, it became Central Europe's leading event IT service provider during the last 10 years. You can meet its staff and its self-developed Backstage Ticketing ecosystem at several domestic and international events, including award-winning music festivals like Sziget (HU) and Untold (RO).
Learn more at www.netpositive.hu.
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the largest library of document templates in the world, we create breakthrough technologies in document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security or speed. Regula was repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604833546/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
